Minnesota Oncology Hematology, PA — Minneapolis, Minnesota

Minnesota Oncology Hematology, PA is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology, PA has participated in 16 clinical trials with 2 currently active.

Therapeutic areas: HER2 Positive Breast Cancer, Colorectal Neoplasms, Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Puma Biotechnology, Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology, PA?

Minnesota Oncology Hematology, PA has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology, PA conducted?

Minnesota Oncology Hematology, PA has 16 clinical trials on record, with 2 currently active. Their work covers HER2 Positive Breast Cancer, Colorectal Neoplasms, Breast Cancer.

Is Minnesota Oncology Hematology, PA accredited by Crixeo Health?

Yes — Minnesota Oncology Hematology, PA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Minnesota Oncology Hematology, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.